首页 > 最新文献

Medical Hypothesis, Discovery, and Innovation in Ophthalmology最新文献

英文 中文
Refractive surgery to correct visual impairments in 267 children with autism spectrum and related neuro-developmental disorders: improvements in vision and behavior. 为 267 名患有自闭症谱系障碍和相关神经发育障碍的儿童实施屈光手术矫正视力障碍:改善视力和行为。
Q2 Medicine Pub Date : 2024-08-14 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1499
Margaret Reynolds, Nicholas Faron, James Hoekel, Lawrence Tychsen

Background: Children with autism spectrum disorder (ASD) may have impaired vision owing to high refractive errors and aversion to spectacles or contact lenses. Visual blurring is caused by near-sighted myopia, far-sighted hyperopia, or astigmatism in one or both eyes. Refractive surgery can restore sharp vision and eliminate the need for spectacles and contact lenses. Restoration of sharp vision may improve ASD behavior. We aimed to determine the refractive outcomes in this cohort using ophthalmic measures and behavioral and school performance alterations after refractive surgery by employing parent-proxy reports.

Methods: This interventional, retrospective case series included data from 267 children with refractive errors and neurodevelopmental disorders (NDDs) diagnosed as ASD alone or NDD with ASD-like behaviors over a 15-year period. One of three refractive surgery methods was employed, with the choice of method uniquely tailored to the child's eye anatomy. Laser photorefractive keratectomy (PRK) was performed in 131 children, implantation of a phakic intraocular lens (pIOL) in 115 children, and removal of the crystalline lens and implantation of an intraocular lens (refractive lens exchange, RLE) in 21 children. All procedures were performed under brief general anesthesia, with the child returning home on the same day.

Results: The median age at surgery was 10.9 years and the median follow-up period was 3.1 years. Pre-operative refractive errors ranged from a mean (standard deviation) +7.5 (0.09) D to -14.3 (4.8) D. Surgery corrected 87% of the children to normal focal length (± 1 D). Visual acuity improved an average of 0.6 logarithm of the minimum angle of resolution, the equivalent of 6 lines on a standard eye chart. Change in visual acuity was significant (all P < 0.01) between baseline and the most recent follow-up examination in each of subgroups. Change in spherical equivalent refractive error at 3, 12, 24, 36, 60, and > 60 months post-operatively were significant (all P < 0.01) between baseline and each follow-up visit in each of subgroups. Social interactions and ASD behaviors improved in 72% (192) of the treated children (P < 0.01). The incidence of sight-threatening complications was low.

Conclusions: Refractive surgery improves both visual function and behavior in most children with ASD and major myopia, hyperopia, or astigmatism. The PRK, pIOL, and RLE procedures appear to be effective and reasonably safe methods for improving refractive error, visual acuity, and behavior in many ametropic children with ASD and ASD-like NDDs.

背景:患有自闭症谱系障碍(ASD)的儿童可能会因屈光不正和对眼镜或隐形眼镜的厌恶而导致视力受损。视力模糊的原因是单眼或双眼近视、远视或散光。屈光手术可以恢复敏锐的视力,不再需要佩戴眼镜和隐形眼镜。恢复敏锐视力可改善 ASD 行为。我们的目的是通过眼科测量方法确定该组患者的屈光治疗效果,并通过家长代理报告确定屈光手术后行为和学习成绩的改变:该干预性、回顾性病例系列包括267名患有屈光不正和神经发育障碍(NDD)的儿童的数据,这些儿童在15年期间被诊断为单纯ASD或NDD伴有类似ASD的行为。他们采用了三种屈光手术方法中的一种,并根据儿童的眼部解剖结构选择了独特的方法。131 名儿童接受了激光光屈光性角膜切除术(PRK),115 名儿童接受了角膜内人工晶体植入术(pIOL),21 名儿童接受了晶体摘除和人工晶体植入术(屈光性晶状体置换术,RLE)。所有手术均在简短的全身麻醉下进行,患儿当天即可回家:手术年龄中位数为 10.9 岁,随访时间中位数为 3.1 年。术前屈光不正从平均值(标准差)+7.5 (0.09) D到-14.3 (4.8) D不等。手术将87%的儿童矫正到正常焦距(± 1 D)。视力平均提高了最小分辨角的 0.6 对数,相当于标准眼图上的 6 行。在每个亚组中,基线与最近一次随访检查之间的视力变化都很明显(所有 P 均小于 0.01)。术后 3、12、24、36、60 个月和超过 60 个月时,每个亚组的球面等效屈光度数在基线和每次随访之间的变化均有显著性(所有 P 均小于 0.01)。72%(192 名)接受治疗的儿童的社交互动和自闭症行为得到改善(P < 0.01)。威胁视力的并发症发生率很低:结论:对于大多数患有严重近视、远视或散光的 ASD 儿童来说,屈光手术可改善他们的视觉功能和行为。PRK、pIOL和RLE手术似乎是改善屈光不正、视力和行为的有效且相当安全的方法,适用于许多患有ASD和类似ASD的NDD的各向异性儿童。
{"title":"Refractive surgery to correct visual impairments in 267 children with autism spectrum and related neuro-developmental disorders: improvements in vision and behavior.","authors":"Margaret Reynolds, Nicholas Faron, James Hoekel, Lawrence Tychsen","doi":"10.51329/mehdiophthal1499","DOIUrl":"10.51329/mehdiophthal1499","url":null,"abstract":"<p><strong>Background: </strong>Children with autism spectrum disorder (ASD) may have impaired vision owing to high refractive errors and aversion to spectacles or contact lenses. Visual blurring is caused by near-sighted myopia, far-sighted hyperopia, or astigmatism in one or both eyes. Refractive surgery can restore sharp vision and eliminate the need for spectacles and contact lenses. Restoration of sharp vision may improve ASD behavior. We aimed to determine the refractive outcomes in this cohort using ophthalmic measures and behavioral and school performance alterations after refractive surgery by employing parent-proxy reports.</p><p><strong>Methods: </strong>This interventional, retrospective case series included data from 267 children with refractive errors and neurodevelopmental disorders (NDDs) diagnosed as ASD alone or NDD with ASD-like behaviors over a 15-year period. One of three refractive surgery methods was employed, with the choice of method uniquely tailored to the child's eye anatomy. Laser photorefractive keratectomy (PRK) was performed in 131 children, implantation of a phakic intraocular lens (pIOL) in 115 children, and removal of the crystalline lens and implantation of an intraocular lens (refractive lens exchange, RLE) in 21 children. All procedures were performed under brief general anesthesia, with the child returning home on the same day.</p><p><strong>Results: </strong>The median age at surgery was 10.9 years and the median follow-up period was 3.1 years. Pre-operative refractive errors ranged from a mean (standard deviation) +7.5 (0.09) D to -14.3 (4.8) D. Surgery corrected 87% of the children to normal focal length (± 1 D). Visual acuity improved an average of 0.6 logarithm of the minimum angle of resolution, the equivalent of 6 lines on a standard eye chart. Change in visual acuity was significant (all <i>P</i> < 0.01) between baseline and the most recent follow-up examination in each of subgroups. Change in spherical equivalent refractive error at 3, 12, 24, 36, 60, and > 60 months post-operatively were significant (all <i>P</i> < 0.01) between baseline and each follow-up visit in each of subgroups. Social interactions and ASD behaviors improved in 72% (192) of the treated children (<i>P</i> < 0.01). The incidence of sight-threatening complications was low.</p><p><strong>Conclusions: </strong>Refractive surgery improves both visual function and behavior in most children with ASD and major myopia, hyperopia, or astigmatism. The PRK, pIOL, and RLE procedures appear to be effective and reasonably safe methods for improving refractive error, visual acuity, and behavior in many ametropic children with ASD and ASD-like NDDs.</p>","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 2","pages":"88-95"},"PeriodicalIF":0.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual, ocular surface, and extraocular diagnostic criteria for determining the prevalence of computer vision syndrome: a cross-sectional smart-survey-based study. 确定电脑视觉综合症发病率的视觉、眼表和眼外诊断标准:一项基于智能调查的横断面研究。
Q2 Medicine Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1489
Mohammed Iqbal, Ahmed Elmassry, Mervat Elgharieb, Omar Said, Ahmed Saeed, Tamer Ibrahim, Ahmed Kotb, Mahmoud Abdelhalim, Samir Shoughy, Akram Elgazzar, Hassan Shamselden, Abdallah Hammour, Mohammed Eid, Hosam Elzembely, Khaled Abdelaziz

Background: The American Optometric Association defines computer vision syndrome (CVS), also known as digital eye strain, as "a group of eye- and vision-related problems that result from prolonged computer, tablet, e-reader and cell phone use". We aimed to create a well-structured, valid, and reliable questionnaire to determine the prevalence of CVS, and to analyze the visual, ocular surface, and extraocular sequelae of CVS using a novel and smart self-assessment questionnaire.

Methods: This multicenter, observational, cross-sectional, descriptive, survey-based, online study included 6853 complete online responses of medical students from 15 universities. All participants responded to the updated, online, fourth version of the CVS questionnaire (CVS-F4), which has high validity and reliability. CVS was diagnosed according to five basic diagnostic criteria (5DC) derived from the CVS-F4. Respondents who fulfilled the 5DC were considered CVS cases. The 5DC were then converted into a novel five-question self-assessment questionnaire designated as the CVS-Smart.

Results: Of 10 000 invited medical students, 8006 responded to the CVS-F4 survey (80% response rate), while 6853 of the 8006 respondents provided complete online responses (85.6% completion rate). The overall CVS prevalence was 58.78% (n = 4028) among the study respondents; CVS prevalence was higher among women (65.87%) than among men (48.06%). Within the CVS group, the most common visual, ocular surface, and extraocular complaints were eye strain, dry eye, and neck/shoulder/back pain in 74.50% (n = 3001), 58.27% (n = 2347), and 80.52% (n = 3244) of CVS cases, respectively. Notably, 75.92% (3058/4028) of CVS cases were involved in the Mandated Computer System Use Program. Multivariate logistic regression analysis revealed that the two most statistically significant diagnostic criteria of the 5DC were ≥2 symptoms/attacks per month over the last 12 months (odds ratio [OR] = 204177.2; P <0.0001) and symptoms/attacks associated with screen use (OR = 16047.34; P <0.0001). The CVS-Smart demonstrated a Cronbach's alpha reliability coefficient of 0.860, Guttman split-half coefficient of 0.805, with perfect content and construct validity. A CVS-Smart score of 7-10 points indicated the presence of CVS.

Conclusions: The visual, ocular surface, and extraocular diagnostic criteria for CVS constituted the basic components of CVS-Smart. CVS-Smart is a novel, valid, reliable, subjective instrument for determining CVS diagnosis and prevalence and may provide a tool for rapid periodic assessment and prognostication. Individuals with positive CVS-Smart results should consider modifying their lifestyles and screen styles and seeking the help of ophthalmologists and/or optometrists. Higher institutional authorities should consider revising the Mandated Computer System Use Program to avoid the long-term consequenc

背景:美国验光协会将电脑视觉综合症(CVS)定义为 "因长时间使用电脑、平板电脑、电子阅读器和手机而导致的一组眼睛和视力相关问题",也称为数码眼疲劳。我们旨在制作一份结构合理、有效且可靠的问卷,以确定 CVS 的患病率,并使用新颖、智能的自我评估问卷分析 CVS 的视觉、眼表和眼外后遗症:这项多中心、观察性、横断面、描述性、基于调查的在线研究包括来自 15 所大学的 6853 名医学生的完整在线回复。所有参与者都回答了最新的第四版在线 CVS 问卷(CVS-F4),该问卷具有很高的有效性和可靠性。根据 CVS-F4 得出的五个基本诊断标准(5DC)对 CVS 进行诊断。符合 5DC 标准的受访者被视为 CVS 病例。然后,将 5DC 转换成新颖的五问自评问卷,称为 CVS-Smart:结果:在 10 000 名受邀医学生中,有 8006 人对 CVS-F4 调查做出了回复(回复率为 80%),其中 6853 人提供了完整的在线回复(完成率为 85.6%)。研究受访者的总体 CVS 患病率为 58.78%(n = 4028);女性的 CVS 患病率(65.87%)高于男性(48.06%)。在 CVS 群体中,最常见的视觉、眼表和眼外主诉是眼疲劳、干眼症和颈/肩/背疼痛,分别占 CVS 病例的 74.50%(n = 3001)、58.27%(n = 2347)和 80.52%(n = 3244)。值得注意的是,75.92%(3058/4028)的 CVS 病例参与了计算机系统强制使用计划。多变量逻辑回归分析显示,5DC 的两个最具统计学意义的诊断标准是:在过去 12 个月中,每月症状/发作次数≥2 次(几率比 [OR] = 204177.2;P 0.0001)和与屏幕使用相关的症状/发作(OR = 16047.34;P 0.0001)。CVS-Smart的Cronbach's alpha信度系数为0.860,Guttman分半系数为0.805,具有完美的内容效度和结构效度。CVS-Smart得分7-10分表示存在CVS:CVS的视觉、眼表和眼外诊断标准构成了CVS-Smart的基本组成部分。CVS-Smart 是一种新颖、有效、可靠、主观的工具,可用于确定 CVS 的诊断和患病率,并可为快速定期评估和预后提供工具。CVS-Smart 检测结果呈阳性的人应考虑改变生活方式和筛查方式,并寻求眼科医生和/或视光师的帮助。高等院校当局应考虑修订计算机系统强制使用计划,以避免 CVS 对大学生造成长期影响。进一步的研究必须将 CVS-Smart 与其他可用的 CVS 指标(如 CVS 问卷)进行比较,以确定其重复测试的可靠性,并证明其广泛使用的合理性。
{"title":"Visual, ocular surface, and extraocular diagnostic criteria for determining the prevalence of computer vision syndrome: a cross-sectional smart-survey-based study.","authors":"Mohammed Iqbal, Ahmed Elmassry, Mervat Elgharieb, Omar Said, Ahmed Saeed, Tamer Ibrahim, Ahmed Kotb, Mahmoud Abdelhalim, Samir Shoughy, Akram Elgazzar, Hassan Shamselden, Abdallah Hammour, Mohammed Eid, Hosam Elzembely, Khaled Abdelaziz","doi":"10.51329/mehdiophthal1489","DOIUrl":"10.51329/mehdiophthal1489","url":null,"abstract":"<p><strong>Background: </strong>The American Optometric Association defines computer vision syndrome (CVS), also known as digital eye strain, as \"a group of eye- and vision-related problems that result from prolonged computer, tablet, e-reader and cell phone use\". We aimed to create a well-structured, valid, and reliable questionnaire to determine the prevalence of CVS, and to analyze the visual, ocular surface, and extraocular sequelae of CVS using a novel and smart self-assessment questionnaire.</p><p><strong>Methods: </strong>This multicenter, observational, cross-sectional, descriptive, survey-based, online study included 6853 complete online responses of medical students from 15 universities. All participants responded to the updated, online, fourth version of the CVS questionnaire (CVS-F4), which has high validity and reliability. CVS was diagnosed according to five basic diagnostic criteria (5DC) derived from the CVS-F4. Respondents who fulfilled the 5DC were considered CVS cases. The 5DC were then converted into a novel five-question self-assessment questionnaire designated as the CVS-Smart.</p><p><strong>Results: </strong>Of 10 000 invited medical students, 8006 responded to the CVS-F4 survey (80% response rate), while 6853 of the 8006 respondents provided complete online responses (85.6% completion rate). The overall CVS prevalence was 58.78% (n = 4028) among the study respondents; CVS prevalence was higher among women (65.87%) than among men (48.06%). Within the CVS group, the most common visual, ocular surface, and extraocular complaints were eye strain, dry eye, and neck/shoulder/back pain in 74.50% (n = 3001), 58.27% (n = 2347), and 80.52% (n = 3244) of CVS cases, respectively. Notably, 75.92% (3058/4028) of CVS cases were involved in the Mandated Computer System Use Program. Multivariate logistic regression analysis revealed that the two most statistically significant diagnostic criteria of the 5DC were ≥2 symptoms/attacks per month over the last 12 months (odds ratio [OR] = 204177.2; <i>P <</i>0.0001) and symptoms/attacks associated with screen use (OR = 16047.34; <i>P <</i>0.0001). The CVS-Smart demonstrated a Cronbach's alpha reliability coefficient of 0.860, Guttman split-half coefficient of 0.805, with perfect content and construct validity. A CVS-Smart score of 7-10 points indicated the presence of CVS.</p><p><strong>Conclusions: </strong>The visual, ocular surface, and extraocular diagnostic criteria for CVS constituted the basic components of CVS-Smart. CVS-Smart is a novel, valid, reliable, subjective instrument for determining CVS diagnosis and prevalence and may provide a tool for rapid periodic assessment and prognostication. Individuals with positive CVS-Smart results should consider modifying their lifestyles and screen styles and seeking the help of ophthalmologists and/or optometrists. Higher institutional authorities should consider revising the Mandated Computer System Use Program to avoid the long-term consequenc","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 1","pages":"1-15"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aflibercept or ranibizumab for diabetic macular edema. Aflibercept 或 ranibizumab 治疗糖尿病黄斑水肿。
Q2 Medicine Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1490
Mahmoud Abdelhalim Ali Ali, Hanan Saied Hegazy, Mohammed Othman Abdelkhalek Elsayed, Ehab Tharwat, Mona Nabeh Mansour, Mohamed Hassanein, Ezzeldin Ramadan Ezzeldin, Ashraf Mohammed GadElkareem, Essam Mahmoud Abd Ellateef, Ahmed A Elsayed, Ibrahim Hassan Elabd, Mahmoud H Abd Rbu, Ramy Saleh Amer, Abdel Ghany Ali El Gabbar, Hatem Mahmoud, Hazem Mohamed Abdelhameed, Amr Mohammed Elsayed Abdelkader

Background: Vascular endothelial growth factor (VEGF) is the primary substance involved in retinal barrier breach. VEGF overexpression may cause diabetic macular edema (DME). Laser photocoagulation of the macula is the standard treatment for DME; however, recently, intravitreal anti-VEGF injections have surpassed laser treatment. Our aim was to evaluate the efficacy of intravitreal injections of aflibercept or ranibizumab for managing treatment-naive DME.

Methods: This single-center, retrospective, interventional, comparative study included eyes with visual impairment due to treatment-naive DME that underwent intravitreal injection of either aflibercept 2 mg/0.05 mL or ranibizumab 0.5 mg/0.05 mL at Al-Azhar University Hospitals, Egypt between March 2023 and January 2024. Demographic data and full ophthalmological examination results at baseline and 1, 3, and 6 months post-injection were collected, including the best-corrected distance visual acuity (BCDVA) in logarithm of the minimum angle of resolution (logMAR) notation, slit-lamp biomicroscopy, dilated fundoscopy, and central subfield thickness (CST) measured using spectral-domain optical coherence tomography.

Results: Overall, the 96 eyes of 96 patients with a median (interquartile range [IQR]) age of 57 (10) (range: 20-74) years and a male-to-female ratio of 1:2.7 were allocated to one of two groups with comparable age, sex, diabetes mellitus duration, and presence of other comorbidities (all P >0.05). There was no statistically significant difference in baseline diabetic retinopathy status or DME type between groups (both P >0.05). In both groups, the median (IQR) BCDVA significantly improved from 0.7 (0.8) logMAR at baseline to 0.4 (0.1) logMAR at 6 months post-injection (both P = 0.001), with no statistically significant difference between groups at all follow-up visits (all P >0.05). The median (IQR) CST significantly decreased in the aflibercept group from 347 (166) µm at baseline to 180 (233) µm at 6 months post-injection, and it decreased in the ranibizumab group from 360 (180) µm at baseline to 190 (224) µm at 6 months post-injection (both P = 0.001), with no statistically significant differences between groups at all follow-up visits (all P >0.05). No serious adverse effects were documented in either group.

Conclusions: Ranibizumab and aflibercept were equally effective in achieving the desired anatomical and functional results in patients with treatment-naïve DME in short-term follow-up without significant differences in injection counts between both drugs. Larger prospective, randomized, double-blinded trials with longer follow-up periods are needed to confirm our preliminary results.

背景:血管内皮生长因子(VEGF血管内皮生长因子(VEGF)是参与视网膜屏障破坏的主要物质。血管内皮生长因子过度表达可能导致糖尿病性黄斑水肿(DME)。激光光凝黄斑是治疗糖尿病性黄斑水肿的标准方法,但最近,玻璃体内抗血管内皮生长因子注射已超过了激光治疗。我们的目的是评估玻璃体内注射阿弗利百普或雷尼珠单抗对治疗无效的 DME 的疗效:这项单中心、回顾性、介入性比较研究纳入了2023年3月至2024年1月期间在埃及爱资哈尔大学医院接受阿弗利百普2毫克/0.05毫升或雷尼珠单抗0.5毫克/0.05毫升玻璃体内注射治疗的视力受损的非治疗性DME患者。研究人员收集了基线和注射后1、3、6个月的人口统计学数据和全面的眼科检查结果,包括以最小分辨角对数(logMAR)表示的最佳矫正距离视力(BCDVA)、裂隙灯生物显微镜检查、散瞳眼底镜检查以及使用光谱域光学相干断层扫描测量的中央子场厚度(CST):总的来说,96 名患者的 96 只眼睛被分配到了两组中的一组,两组患者的年龄、性别、糖尿病病程和是否患有其他合并症的情况相当(P 均大于 0.05),中位数(四分位数间距 [IQR])年龄为 57 (10)(范围:20-74)岁,男女比例为 1:2.7。两组间糖尿病视网膜病变的基线状态或 DME 类型无明显统计学差异(均 P >0.05)。两组患者的 BCDVA 中位数(IQR)均从基线时的 0.7 (0.8) logMAR 显著改善至注射后 6 个月时的 0.4 (0.1) logMAR(均为 P = 0.001),在所有随访中,组间差异均无统计学意义(均为 P >0.05)。阿夫利百普组的CST中位数(IQR)从基线时的347(166)µm显著下降到注射后6个月时的180(233)µm,而雷尼珠单抗组的CST中位数从基线时的360(180)µm下降到注射后6个月时的190(224)µm(均为P = 0.001),在所有随访中,组间差异均无统计学意义(均为P >0.05)。两组患者均未出现严重不良反应:结论:在短期随访中,雷珠单抗和阿夫利拜因对治疗无效的DME患者在获得理想的解剖和功能效果方面同样有效,两种药物的注射次数无明显差异。要证实我们的初步结果,还需要更大规模、更长随访期的前瞻性、随机、双盲试验。
{"title":"Aflibercept or ranibizumab for diabetic macular edema.","authors":"Mahmoud Abdelhalim Ali Ali, Hanan Saied Hegazy, Mohammed Othman Abdelkhalek Elsayed, Ehab Tharwat, Mona Nabeh Mansour, Mohamed Hassanein, Ezzeldin Ramadan Ezzeldin, Ashraf Mohammed GadElkareem, Essam Mahmoud Abd Ellateef, Ahmed A Elsayed, Ibrahim Hassan Elabd, Mahmoud H Abd Rbu, Ramy Saleh Amer, Abdel Ghany Ali El Gabbar, Hatem Mahmoud, Hazem Mohamed Abdelhameed, Amr Mohammed Elsayed Abdelkader","doi":"10.51329/mehdiophthal1490","DOIUrl":"10.51329/mehdiophthal1490","url":null,"abstract":"<p><strong>Background: </strong>Vascular endothelial growth factor (VEGF) is the primary substance involved in retinal barrier breach. VEGF overexpression may cause diabetic macular edema (DME). Laser photocoagulation of the macula is the standard treatment for DME; however, recently, intravitreal anti-VEGF injections have surpassed laser treatment. Our aim was to evaluate the efficacy of intravitreal injections of aflibercept or ranibizumab for managing treatment-naive DME.</p><p><strong>Methods: </strong>This single-center, retrospective, interventional, comparative study included eyes with visual impairment due to treatment-naive DME that underwent intravitreal injection of either aflibercept 2 mg/0.05 mL or ranibizumab 0.5 mg/0.05 mL at Al-Azhar University Hospitals, Egypt between March 2023 and January 2024. Demographic data and full ophthalmological examination results at baseline and 1, 3, and 6 months post-injection were collected, including the best-corrected distance visual acuity (BCDVA) in logarithm of the minimum angle of resolution (logMAR) notation, slit-lamp biomicroscopy, dilated fundoscopy, and central subfield thickness (CST) measured using spectral-domain optical coherence tomography.</p><p><strong>Results: </strong>Overall, the 96 eyes of 96 patients with a median (interquartile range [IQR]) age of 57 (10) (range: 20-74) years and a male-to-female ratio of 1:2.7 were allocated to one of two groups with comparable age, sex, diabetes mellitus duration, and presence of other comorbidities (all <i>P</i> >0.05). There was no statistically significant difference in baseline diabetic retinopathy status or DME type between groups (both <i>P</i> >0.05). In both groups, the median (IQR) BCDVA significantly improved from 0.7 (0.8) logMAR at baseline to 0.4 (0.1) logMAR at 6 months post-injection (both <i>P</i> = 0.001), with no statistically significant difference between groups at all follow-up visits (all <i>P</i> >0.05). The median (IQR) CST significantly decreased in the aflibercept group from 347 (166) µm at baseline to 180 (233) µm at 6 months post-injection, and it decreased in the ranibizumab group from 360 (180) µm at baseline to 190 (224) µm at 6 months post-injection (both <i>P</i> = 0.001), with no statistically significant differences between groups at all follow-up visits (all <i>P</i> >0.05). No serious adverse effects were documented in either group.</p><p><strong>Conclusions: </strong>Ranibizumab and aflibercept were equally effective in achieving the desired anatomical and functional results in patients with treatment-naïve DME in short-term follow-up without significant differences in injection counts between both drugs. Larger prospective, randomized, double-blinded trials with longer follow-up periods are needed to confirm our preliminary results.</p>","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 1","pages":"16-26"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal densitometry changes after femtosecond laser-assisted intracorneal ring segments implantation in keratoconus. 飞秒激光辅助角膜内环节段植入术后角膜密度的变化。
Q2 Medicine Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1491
Amr Mounir, Engy Mohamed Mostafa, Ibrahim Amer, Ahmed Abdelaleem Abdelgbar, Hamdy Osman Osman, Mostafa Abdelrahman Ahmed, Hossam Ziada, Abdel Ghany Ali El Gabbar, Mohamed Alsadawy Hassan, Alaa Mahmoud

Background: Intrastromal corneal ring segments are commonly implanted in the corneas of eyes with mild-to-moderate keratoconus; however, changes in corneal densitometry (CD) after implantation are a matter of debate in the current literature. We evaluated the changes in CD 1 and 3 months after femtosecond laser-assisted Keraring implantation.

Methods: This retrospective, non-comparative, multicenter, case series study included patients with keratoconus who underwent femtosecond laser-assisted implantation of double segments with 90° and 160° arc lengths or two 160° arc length Keraring segments. Demographic and baseline clinical ophthalmic data were recorded. Corneal topography and tomography data acquired using a Pentacam HR Scheimpflug tomography system (Pentacam High Resolution; Oculus, Wetzlar, Germany) with a best-fit sphere were used as a reference surface. Using the Pentacam HR, CD measurements were acquired over a corneal area of 12 mm in total and at four concentric zones (0-2, 2-6, 6-10, and 10-12 mm) of three corneal stromal depths: 120 μm of the anterior corneal stromal layer, 60 μm of the posterior corneal stromal layer, and the central layer of stroma lying between these two layers.

Results: We included 40 eyes of 40 patients, including 8 (20%) male and 32 (80%) female individuals, with a mean (standard deviation) age of 21.0 (6.4) years. We observed a significant improvement in the topographic values of steep keratometry (K), flat K, maximum K, and corneal astigmatism (all P < 0.05), but not in the mean K, thinnest corneal pachymetry, corneal thickness at the apex, back elevation, or front elevation (all P > 0.05). The mean total anterior, central, and posterior CD differed significantly among the time points, with a significant increase from the preoperative to the 1-month and 3-month postoperative visits (all P < 0.05) and no difference between those of the 1-month and 3-month postoperative visits (all P > 0.05). The mean CD for the anterior layer in the central, paracentral, and mid-peripheral zones, and the central layer in all four zones, differed significantly among time points, with a significant increase from the preoperative to the 1-month and 3-month postoperative visits (all P < 0.05), which remained unchanged from the 1-month to the 3-month postoperative visit (all P < 0.05), except for the central 2-6-mm zone, which decreased significantly from the 1-month to the 3-month postoperative visit (P < 0.001). The CD of the central 10-12-mm zone did not differ significantly in each pairwise comparison (all P > 0.05). In contrast, CD for the posterior layer in the paracentral zone decreased significantly from the preoperative to the 1-month and 3-month postoperative visits but increased, to a lesser extent, from the 1-month to the 3-month postoperative visit (all P < 0.05).

Conclusions: Femtosecond laser-assisted Keraring implantation signi

背景:在轻度至中度角膜炎患者的角膜上通常会植入基质内角膜环段;然而,植入后角膜密度(CD)的变化在目前的文献中还存在争议。我们评估了飞秒激光辅助角膜塑形镜植入术后 1 个月和 3 个月 CD 的变化:这项回顾性、非比较性、多中心、病例系列研究纳入了在飞秒激光辅助下植入 90° 和 160° 弧长双节段或两个 160° 弧长 Keraring 节段的角膜炎患者。记录了人口统计学和眼科临床基线数据。使用 Pentacam HR Scheimpflug 层析成像系统(Pentacam 高分辨率;Oculus,德国,Wetzlar)采集的角膜地形图和层析成像数据以最佳拟合球面为参考面。使用 Pentacam HR,在总长度为 12 毫米的角膜区域和三个角膜基质深度的四个同心区(0-2、2-6、6-10 和 10-12 毫米)进行了 CD 测量:角膜前基质层 120 微米,角膜后基质层 60 微米,以及位于这两层之间的中央基质层:我们共纳入了 40 名患者的 40 只眼睛,其中男性 8 名(占 20%),女性 32 名(占 80%),平均年龄(标准差)为 21.0(6.4)岁。我们观察到,陡角膜度数(K)、平角膜度数、最大角膜度数和角膜散光的地形学值均有明显改善(P 均小于 0.05),但平均角膜度数、最薄角膜厚度、角膜顶点厚度、后方抬高和前方抬高的地形学值均无明显改善(P 均大于 0.05)。术前、术后 1 个月和 3 个月的前层、中央层和后层平均总 CD 值在不同时间点之间差异显著,术前显著增加(所有 P 均小于 0.05),术后 1 个月和 3 个月没有差异(所有 P 均大于 0.05)。中央区、旁中心区和中外周区前层以及所有四个区中央层的平均 CD 在不同时间点有显著差异,术前至术后 1 个月和 3 个月的平均 CD 显著增加(均 P < 0.05),从术后 1 个月到术后 3 个月就诊时保持不变(均 P <0.05),只有中央 2-6 mm 区从术后 1 个月到术后 3 个月就诊时明显减少(P <0.001)。中央 10-12 毫米区的 CD 在每对比较中均无明显差异(均 P > 0.05)。与此相反,旁中心区后层的 CD 从术前到术后 1 个月和 3 个月时明显减少,但从术后 1 个月到术后 3 个月时增加较少(均 P <0.05):结论:飞秒激光辅助下的 Keraring 植入术能显著改变 CD,改善大多数地形参数。要验证这些初步研究结果,还需要更多样本量的纵向研究。
{"title":"Corneal densitometry changes after femtosecond laser-assisted intracorneal ring segments implantation in keratoconus.","authors":"Amr Mounir, Engy Mohamed Mostafa, Ibrahim Amer, Ahmed Abdelaleem Abdelgbar, Hamdy Osman Osman, Mostafa Abdelrahman Ahmed, Hossam Ziada, Abdel Ghany Ali El Gabbar, Mohamed Alsadawy Hassan, Alaa Mahmoud","doi":"10.51329/mehdiophthal1491","DOIUrl":"10.51329/mehdiophthal1491","url":null,"abstract":"<p><strong>Background: </strong>Intrastromal corneal ring segments are commonly implanted in the corneas of eyes with mild-to-moderate keratoconus; however, changes in corneal densitometry (CD) after implantation are a matter of debate in the current literature. We evaluated the changes in CD 1 and 3 months after femtosecond laser-assisted Keraring implantation.</p><p><strong>Methods: </strong>This retrospective, non-comparative, multicenter, case series study included patients with keratoconus who underwent femtosecond laser-assisted implantation of double segments with 90° and 160° arc lengths or two 160° arc length Keraring segments. Demographic and baseline clinical ophthalmic data were recorded. Corneal topography and tomography data acquired using a Pentacam HR Scheimpflug tomography system (Pentacam High Resolution; Oculus, Wetzlar, Germany) with a best-fit sphere were used as a reference surface. Using the Pentacam HR, CD measurements were acquired over a corneal area of 12 mm in total and at four concentric zones (0-2, 2-6, 6-10, and 10-12 mm) of three corneal stromal depths: 120 μm of the anterior corneal stromal layer, 60 μm of the posterior corneal stromal layer, and the central layer of stroma lying between these two layers.</p><p><strong>Results: </strong>We included 40 eyes of 40 patients, including 8 (20%) male and 32 (80%) female individuals, with a mean (standard deviation) age of 21.0 (6.4) years. We observed a significant improvement in the topographic values of steep keratometry (K), flat K, maximum K, and corneal astigmatism (all P < 0.05), but not in the mean K, thinnest corneal pachymetry, corneal thickness at the apex, back elevation, or front elevation (all P > 0.05). The mean total anterior, central, and posterior CD differed significantly among the time points, with a significant increase from the preoperative to the 1-month and 3-month postoperative visits (all P < 0.05) and no difference between those of the 1-month and 3-month postoperative visits (all P > 0.05). The mean CD for the anterior layer in the central, paracentral, and mid-peripheral zones, and the central layer in all four zones, differed significantly among time points, with a significant increase from the preoperative to the 1-month and 3-month postoperative visits (all P < 0.05), which remained unchanged from the 1-month to the 3-month postoperative visit (all P < 0.05), except for the central 2-6-mm zone, which decreased significantly from the 1-month to the 3-month postoperative visit (P < 0.001). The CD of the central 10-12-mm zone did not differ significantly in each pairwise comparison (all P > 0.05). In contrast, CD for the posterior layer in the paracentral zone decreased significantly from the preoperative to the 1-month and 3-month postoperative visits but increased, to a lesser extent, from the 1-month to the 3-month postoperative visit (all P < 0.05).</p><p><strong>Conclusions: </strong>Femtosecond laser-assisted Keraring implantation signi","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 1","pages":"27-34"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fenofibrate and diabetic retinopathy. 非诺贝特和糖尿病视网膜病变。
Q2 Medicine Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1492
Omer Karti, Ali Osman Saatci

Background: Diabetic retinopathy (DR), a sight-threatening ocular complication of diabetes mellitus, is one of the main causes of blindness in the working-age population. Dyslipidemia is a potential risk factor for the development or worsening of DR, with conflicting evidence in epidemiological studies. Fenofibrate, an antihyperlipidemic agent, has lipid-modifying and pleiotropic (non-lipid) effects that may lessen the incidence of microvascular events.

Methods: Relevant studies were identified through a PubMed/MEDLINE search spanning the last 20 years, using the broad term "diabetic retinopathy" and specific terms "fenofibrate" and "dyslipidemia". References cited in these studies were further examined to compile this mini-review. These pivotal investigations underwent meticulous scrutiny and synthesis, focusing on methodological approaches and clinical outcomes. Furthermore, we provided the main findings of the seminal studies in a table to enhance comprehension and comparison.

Results: Growing evidence indicates that fenofibrate treatment slows DR advancement owing to its possible protective effects on the blood-retinal barrier. The protective attributes of fenofibrate against DR progression and development can be broadly classified into two categories: lipid-modifying effects and non-lipid-related (pleiotropic) effects. The lipid-modifying effect is mediated through peroxisome proliferator-activated receptor-α activation, while the pleiotropic effects involve the reduction in serum levels of C-reactive protein, fibrinogen, and pro-inflammatory markers, and improvement in flow-mediated dilatation. In patients with DR, the lipid-modifying effects of fenofibrate primarily involve a reduction in lipoprotein-associated phospholipase A2 levels and the upregulation of apolipoprotein A1 levels. These changes contribute to the anti-inflammatory and anti-angiogenic effects of fenofibrate. Fenofibrate elicits a diverse array of pleiotropic effects, including anti-apoptotic, antioxidant, anti-inflammatory, and anti-angiogenic properties, along with the indirect consequences of these effects. Two randomized controlled trials-the Fenofibrate Intervention and Event Lowering in Diabetes and Action to Control Cardiovascular Risk in Diabetes studies-noted that fenofibrate treatment protected against DR progression, independent of serum lipid levels.

Conclusions: Fenofibrate, an oral antihyperlipidemic agent that is effective in decreasing DR progression, may reduce the number of patients who develop vision-threatening complications and require invasive treatment. Despite its proven protection against DR progression, fenofibrate treatment has not yet gained wide clinical acceptance in DR management. Ongoing and future clinical trials may clarify the role of fenofibrate treatment in DR management.

背景:糖尿病视网膜病变(DR)是糖尿病的一种危及视力的眼部并发症,是工作年龄人口失明的主要原因之一。血脂异常是导致糖尿病视网膜病变发生或恶化的潜在风险因素,但流行病学研究中的证据并不一致。非诺贝特是一种抗高血脂药物,具有调节血脂和多生物效应(非血脂),可降低微血管事件的发生率:使用 "糖尿病视网膜病变 "这一宽泛术语以及 "非诺贝特 "和 "血脂异常 "这两个特定术语,在 PubMed/MEDLINE 上搜索过去 20 年中的相关研究。我们对这些研究中引用的参考文献进行了进一步研究,从而编写了这篇微型综述。我们对这些关键性研究进行了细致的审查和综合,重点关注研究方法和临床结果。此外,我们还以表格的形式提供了这些重要研究的主要发现,以加深理解和比较:越来越多的证据表明,非诺贝特对血液-视网膜屏障可能具有保护作用,因此能延缓 DR 的发展。非诺贝特对 DR 进展和发展的保护作用可大致分为两类:脂质调节作用和非脂质相关(多效)作用。调脂作用是通过激活过氧化物酶体增殖物激活受体-α介导的,而多效应则涉及降低血清中 C 反应蛋白、纤维蛋白原和促炎症标志物的水平,以及改善血流介导的扩张。在 DR 患者中,非诺贝特的调脂作用主要包括降低脂蛋白相关磷脂酶 A2 的水平和上调载脂蛋白 A1 的水平。这些变化促成了非诺贝特的抗炎和抗血管生成作用。非诺贝特具有多种多样的多生物效应,包括抗细胞凋亡、抗氧化、抗炎和抗血管生成特性,以及这些效应的间接后果。两项随机对照试验--"非诺贝特干预和降低糖尿病事件发生率 "和 "控制糖尿病心血管风险行动"--指出,非诺贝特治疗可防止糖尿病恶化,与血清脂质水平无关:结论:非诺贝特是一种口服抗高血脂药物,可有效降低 DR 的进展,并可减少出现危及视力的并发症和需要进行侵入性治疗的患者人数。尽管非诺贝特能有效防止 DR 的恶化,但在 DR 的临床治疗中尚未被广泛接受。正在进行的和未来的临床试验可能会明确非诺贝特治疗在 DR 治疗中的作用。
{"title":"Fenofibrate and diabetic retinopathy.","authors":"Omer Karti, Ali Osman Saatci","doi":"10.51329/mehdiophthal1492","DOIUrl":"10.51329/mehdiophthal1492","url":null,"abstract":"<p><strong>Background: </strong>Diabetic retinopathy (DR), a sight-threatening ocular complication of diabetes mellitus, is one of the main causes of blindness in the working-age population. Dyslipidemia is a potential risk factor for the development or worsening of DR, with conflicting evidence in epidemiological studies. Fenofibrate, an antihyperlipidemic agent, has lipid-modifying and pleiotropic (non-lipid) effects that may lessen the incidence of microvascular events.</p><p><strong>Methods: </strong>Relevant studies were identified through a PubMed/MEDLINE search spanning the last 20 years, using the broad term \"diabetic retinopathy\" and specific terms \"fenofibrate\" and \"dyslipidemia\". References cited in these studies were further examined to compile this mini-review. These pivotal investigations underwent meticulous scrutiny and synthesis, focusing on methodological approaches and clinical outcomes. Furthermore, we provided the main findings of the seminal studies in a table to enhance comprehension and comparison.</p><p><strong>Results: </strong>Growing evidence indicates that fenofibrate treatment slows DR advancement owing to its possible protective effects on the blood-retinal barrier. The protective attributes of fenofibrate against DR progression and development can be broadly classified into two categories: lipid-modifying effects and non-lipid-related (pleiotropic) effects. The lipid-modifying effect is mediated through peroxisome proliferator-activated receptor-α activation, while the pleiotropic effects involve the reduction in serum levels of C-reactive protein, fibrinogen, and pro-inflammatory markers, and improvement in flow-mediated dilatation. In patients with DR, the lipid-modifying effects of fenofibrate primarily involve a reduction in lipoprotein-associated phospholipase A2 levels and the upregulation of apolipoprotein A1 levels. These changes contribute to the anti-inflammatory and anti-angiogenic effects of fenofibrate. Fenofibrate elicits a diverse array of pleiotropic effects, including anti-apoptotic, antioxidant, anti-inflammatory, and anti-angiogenic properties, along with the indirect consequences of these effects. Two randomized controlled trials-the Fenofibrate Intervention and Event Lowering in Diabetes and Action to Control Cardiovascular Risk in Diabetes studies-noted that fenofibrate treatment protected against DR progression, independent of serum lipid levels.</p><p><strong>Conclusions: </strong>Fenofibrate, an oral antihyperlipidemic agent that is effective in decreasing DR progression, may reduce the number of patients who develop vision-threatening complications and require invasive treatment. Despite its proven protection against DR progression, fenofibrate treatment has not yet gained wide clinical acceptance in DR management. Ongoing and future clinical trials may clarify the role of fenofibrate treatment in DR management.</p>","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 1","pages":"35-43"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of chronic sixth cranial nerve palsy: case report and literature review. 慢性第六颅神经麻痹的手术治疗:病例报告和文献综述。
Q2 Medicine Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1494
Christine Hakimeh, Kourosh Shahraki, Luc Courtois, Donny W Suh

Background: Esotropia resulting from sixth cranial nerve palsy can substantially impact an individual's visual acuity and overall quality of life. If the condition does not resolve in 6-10 months, surgical intervention may be necessary. Various muscle surgeries may be considered, with vertical rectus muscle transposition emerging as the primary option for treatment of complete palsy. However, this technique carries the risk of anterior segment ischemia and post-surgery deviations. Herein, we present a successful treatment of chronic complete sixth nerve palsy using a modified Nishida procedure, without splitting or tenotomy, and an adjunct botulinum toxin A (BTA) injection in the ipsilateral medial rectus muscle.

Case presentation: A 59-year-old woman with a history of traumatic sixth nerve palsy had previously undergone horizontal muscle strabismus surgeries. Following multiple left medial rectus recessions, lateral rectus resection, and BTA injections, esotropia persisted. The worsening of her condition led to emotional distress and impaired social interaction. Initial examination revealed marked esotropia and limited left eye abduction. Magnetic resonance imaging (SIGNA MR750w, GE Healthcare, Waukesha, WI, USA) of the left eye revealed a contracted medial rectus muscle and substantial atrophy of the left lateral rectus muscle. A modified Nishida procedure was performed with an injection of 3 units of BTA into the ipsilateral medial rectus muscle, resulting in improved ocular alignment and stable findings after nine postoperative months. Furthermore, we supported our successful outcome with a summary of similar reported cases of sixth nerve palsy managed using the modified Nishida procedure with or without adjunctive procedures.

Conclusions: Following the modified Nishida procedure, the patient experienced a reduction in diplopia, improved ocular alignment and stability, and an increased binocular diplopia-free field. This case underscores the importance of an individualized approach to complex strabismus cases and highlights the modified Nishida procedure as a valuable tool in such circumstances. In the future, strabismus management will focus on refining personalized treatment and exploring innovative techniques for complex cases. Our success in using a combination of Nishida procedure and BTA injection should be further investigated in large-scale studies.

背景:第六颅神经麻痹导致的内斜视会严重影响患者的视力和整体生活质量。如果病情在 6-10 个月内仍未缓解,可能需要进行手术治疗。可以考虑进行各种肌肉手术,其中垂直直肌转位术是治疗完全性麻痹的主要选择。然而,这种技术存在前节缺血和术后偏差的风险。在此,我们介绍了一种成功治疗慢性完全性第六神经麻痹的方法,该方法采用改良的西田手术,不进行劈裂或腱膜切开术,同时在同侧内侧直肌注射肉毒杆菌毒素 A (BTA):一名 59 岁的女性,曾有外伤性第六神经麻痹病史,之前接受过水平肌斜视手术。经过多次左侧内侧直肌凹陷、外侧直肌切除和 BTA 注射后,内斜视仍然存在。病情恶化导致她情绪低落,社交能力受损。初步检查发现她有明显的内斜视,左眼外展受限。左眼磁共振成像(SIGNA MR750w,GE Healthcare,Waukesha,WI,USA)显示内侧直肌收缩,左侧外侧直肌严重萎缩。我们采用了改良的西田手术,向同侧内侧直肌注射了 3 个单位的 BTA,术后 9 个月后,患者的眼球对位得到了改善,视力也趋于稳定。此外,我们还总结了使用改良西田手术治疗或不使用辅助手术治疗第六神经麻痹的类似病例,为我们的成功结果提供了佐证:结论:改良西田手术后,患者复视减轻,眼球排列和稳定性得到改善,双眼无复视视野扩大。本病例强调了个体化治疗复杂斜视病例的重要性,并突出了改良西田法在这种情况下的重要作用。未来,斜视治疗的重点将放在完善个性化治疗和探索复杂病例的创新技术上。我们在结合使用西田手术和 BTA 注射法方面取得的成功应在大规模研究中进一步探讨。
{"title":"Surgical management of chronic sixth cranial nerve palsy: case report and literature review.","authors":"Christine Hakimeh, Kourosh Shahraki, Luc Courtois, Donny W Suh","doi":"10.51329/mehdiophthal1494","DOIUrl":"10.51329/mehdiophthal1494","url":null,"abstract":"<p><strong>Background: </strong>Esotropia resulting from sixth cranial nerve palsy can substantially impact an individual's visual acuity and overall quality of life. If the condition does not resolve in 6-10 months, surgical intervention may be necessary. Various muscle surgeries may be considered, with vertical rectus muscle transposition emerging as the primary option for treatment of complete palsy. However, this technique carries the risk of anterior segment ischemia and post-surgery deviations. Herein, we present a successful treatment of chronic complete sixth nerve palsy using a modified Nishida procedure, without splitting or tenotomy, and an adjunct botulinum toxin A (BTA) injection in the ipsilateral medial rectus muscle.</p><p><strong>Case presentation: </strong>A 59-year-old woman with a history of traumatic sixth nerve palsy had previously undergone horizontal muscle strabismus surgeries. Following multiple left medial rectus recessions, lateral rectus resection, and BTA injections, esotropia persisted. The worsening of her condition led to emotional distress and impaired social interaction. Initial examination revealed marked esotropia and limited left eye abduction. Magnetic resonance imaging (SIGNA MR750w, GE Healthcare, Waukesha, WI, USA) of the left eye revealed a contracted medial rectus muscle and substantial atrophy of the left lateral rectus muscle. A modified Nishida procedure was performed with an injection of 3 units of BTA into the ipsilateral medial rectus muscle, resulting in improved ocular alignment and stable findings after nine postoperative months. Furthermore, we supported our successful outcome with a summary of similar reported cases of sixth nerve palsy managed using the modified Nishida procedure with or without adjunctive procedures.</p><p><strong>Conclusions: </strong>Following the modified Nishida procedure, the patient experienced a reduction in diplopia, improved ocular alignment and stability, and an increased binocular diplopia-free field. This case underscores the importance of an individualized approach to complex strabismus cases and highlights the modified Nishida procedure as a valuable tool in such circumstances. In the future, strabismus management will focus on refining personalized treatment and exploring innovative techniques for complex cases. Our success in using a combination of Nishida procedure and BTA injection should be further investigated in large-scale studies.</p>","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 1","pages":"55-62"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227665/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keratoconus: imaging modalities and management. 角膜炎:成像模式和管理。
Q2 Medicine Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.51329/mehdiophthal1493
Noor Alqudah

Background: Keratoconus (KCN) is characterized by gradual thinning and steepening of the cornea, which can lead to significant vision problems owing to high astigmatism, corneal scarring, or even corneal perforation. The detection of KCN in its early stages is crucial for effective treatment. In this review, we describe current advances in the diagnosis and treatment of KCN.

Methods: This narrative review focuses on recent advancements in the diagnosis and treatment of KCN, especially evolving approaches and strategies. To ensure the inclusion of the most recent literature, relevant publications discussing advanced imaging techniques and treatment options for KCN were extensively gathered from the PubMed/MEDLINE and Google Scholar databases. The following index terms and keywords were used for the online search: keratoconus, diagnosis of keratoconus, advances in the diagnosis of keratoconus, topography or tomography, anterior segment optical coherence tomography, treatment of keratoconus, advances in the treatment of keratoconus, collagen crosslinking, intrastromal ring, keratoplasty, and new techniques in keratoconus.

Results: Various screening methods such as corneal topography, tomography, anterior segment optical coherence tomography, and assessment of corneal biomechanics have been developed to identify KCN in its early stages. After diagnosis, KCN management focuses on preventing disease progression. Corneal collagen crosslinking is a minimally invasive treatment that can slow or stop the progression of the condition. Recent research has also explored the use of copper sulfate eye drops (IVMED-80) as a noninvasive treatment to prevent the progression of KCN. Current treatment options for visual improvement include scleral lenses, intracorneal ring segments, corneal allogeneic intrastromal ring segments, and deep anterior lamellar keratoplasty. Recently, novel alternative procedures, such as isolated Bowman layer transplantation, either as a corneal stromal inlay or onlay, have demonstrated encouraging outcomes. Artificial intelligence has gained acceptance for providing best practices for the diagnosis and management of KCN, and the science of its application is contentiously debated; however, it may not have been sufficiently developed.

Conclusions: Early detection and advancements in screening methods using current imaging modalities have improved diagnosis of KCN. Improvement in the accuracy of current screening or diagnostic tests and comparison of their validities are achievable by well-designed, large-scale, prospective studies. The safety and effectiveness of emerging treatments for KCN are currently being investigated. There is an ongoing need for studies to track progress and evaluate clinicians' knowledge and practices in treating patients with KCN. Artificial intelligence capabilities in management approach considering the currently available

背景:角膜炎(KCN)的特征是角膜逐渐变薄和变陡,可因高度散光、角膜瘢痕甚至角膜穿孔而导致严重的视力问题。早期发现 KCN 对有效治疗至关重要。在这篇综述中,我们将介绍目前在诊断和治疗 KCN 方面取得的进展:这篇叙述性综述侧重于 KCN 诊断和治疗的最新进展,尤其是不断发展的方法和策略。为确保纳入最新文献,我们从 PubMed/MEDLINE 和 Google Scholar 数据库中广泛收集了讨论 KCN 先进成像技术和治疗方案的相关出版物。在线搜索使用了以下索引词和关键词:角膜塑形镜、角膜塑形镜诊断、角膜塑形镜诊断进展、地形图或断层扫描、前节光学相干断层扫描、角膜塑形镜治疗、角膜塑形镜治疗进展、胶原交联、基质内环、角膜成形术和角膜塑形镜新技术:已开发出各种筛查方法,如角膜地形图、断层扫描、前节光学相干断层扫描和角膜生物力学评估,以在早期阶段识别 KCN。确诊后,KCN 的治疗重点是防止疾病恶化。角膜胶原交联是一种微创治疗方法,可减缓或阻止病情发展。最近的研究还探索了使用硫酸铜滴眼液(IVMED-80)作为一种非侵入性治疗方法来预防 KCN 的发展。目前改善视力的治疗方法包括巩膜镜、角膜环内切片、角膜同种异体基质环内切片和深前板层角膜移植术。最近,一些新的替代手术,如分离鲍曼层移植术,无论是作为角膜基质镶嵌还是嵌体,都取得了令人鼓舞的效果。人工智能在为 KCN 的诊断和管理提供最佳实践方面已获得认可,但其应用的科学性还存在争议;不过,人工智能可能尚未得到充分发展:结论:使用当前成像模式进行早期检测和筛查方法的进步改善了 KCN 的诊断。通过精心设计的大规模前瞻性研究,可以提高现有筛查或诊断测试的准确性,并对其有效性进行比较。目前正在研究新出现的 KCN 治疗方法的安全性和有效性。目前需要开展研究,跟踪进展情况,评估临床医生在治疗 KCN 患者方面的知识和实践。考虑到目前可用的成像模式和治疗方案,在管理方法中采用人工智能功能将使患者受益匪浅。
{"title":"Keratoconus: imaging modalities and management.","authors":"Noor Alqudah","doi":"10.51329/mehdiophthal1493","DOIUrl":"10.51329/mehdiophthal1493","url":null,"abstract":"<p><strong>Background: </strong>Keratoconus (KCN) is characterized by gradual thinning and steepening of the cornea, which can lead to significant vision problems owing to high astigmatism, corneal scarring, or even corneal perforation. The detection of KCN in its early stages is crucial for effective treatment. In this review, we describe current advances in the diagnosis and treatment of KCN.</p><p><strong>Methods: </strong>This narrative review focuses on recent advancements in the diagnosis and treatment of KCN, especially evolving approaches and strategies. To ensure the inclusion of the most recent literature, relevant publications discussing advanced imaging techniques and treatment options for KCN were extensively gathered from the PubMed/MEDLINE and Google Scholar databases. The following index terms and keywords were used for the online search: keratoconus, diagnosis of keratoconus, advances in the diagnosis of keratoconus, topography or tomography, anterior segment optical coherence tomography, treatment of keratoconus, advances in the treatment of keratoconus, collagen crosslinking, intrastromal ring, keratoplasty, and new techniques in keratoconus.</p><p><strong>Results: </strong>Various screening methods such as corneal topography, tomography, anterior segment optical coherence tomography, and assessment of corneal biomechanics have been developed to identify KCN in its early stages. After diagnosis, KCN management focuses on preventing disease progression. Corneal collagen crosslinking is a minimally invasive treatment that can slow or stop the progression of the condition. Recent research has also explored the use of copper sulfate eye drops (IVMED-80) as a noninvasive treatment to prevent the progression of KCN. Current treatment options for visual improvement include scleral lenses, intracorneal ring segments, corneal allogeneic intrastromal ring segments, and deep anterior lamellar keratoplasty. Recently, novel alternative procedures, such as isolated Bowman layer transplantation, either as a corneal stromal inlay or onlay, have demonstrated encouraging outcomes. Artificial intelligence has gained acceptance for providing best practices for the diagnosis and management of KCN, and the science of its application is contentiously debated; however, it may not have been sufficiently developed.</p><p><strong>Conclusions: </strong>Early detection and advancements in screening methods using current imaging modalities have improved diagnosis of KCN. Improvement in the accuracy of current screening or diagnostic tests and comparison of their validities are achievable by well-designed, large-scale, prospective studies. The safety and effectiveness of emerging treatments for KCN are currently being investigated. There is an ongoing need for studies to track progress and evaluate clinicians' knowledge and practices in treating patients with KCN. Artificial intelligence capabilities in management approach considering the currently available","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"13 1","pages":"44-54"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular injuries sustained at home in five metropolitan cities: a review of 5008 cases. 五个大都市中在家中发生的眼外伤:对 5008 个病例的回顾。
Q2 Medicine Pub Date : 2024-01-31 eCollection Date: 2023-01-01 DOI: 10.51329/mehdiophthal1486
Meisam Sharifi, Mohammad Sedaghat, Mohammad Vaseie

Background: In Iran, ocular injuries sustained at home are a growing public health issue, and few studies have explored their prevalence and the frequencies of different causes of these injuries. We investigated the features of ocular injuries at home among children and adolescents (aged < 18 years), adults (18 - 64 years), and the elderly ( ≥ 65 years) in five metropolitan cities.

Methods: In this cross-sectional study, we recruited individuals with ocular injuries sustained at home who presented to 12 public/teaching hospitals in five metropolitan cities during a 5-month period. Using clinical records within the emergency department archives, we collected the following data: age, sex, frequency of injuries requiring hospital admission or surgical intervention, and causes of eye injuries, documented as 1) cleaning products, 2) chemical products, 3) kitchen items, 4) cooking activities, 5) toys, 6) falls from height, 7) sports equipment, 8) penetrating or cutting, 9) abrasions, 10) foreign bodies, and 11) direct blows by other individuals.

Results: Of 5008 participants from the five cities, 74% (n = 3711) were male and 26% (n = 1297) were female. The most frequent causes of injury among children and adolescents, adults, and the elderly were toys, kitchen items, and cooking activities, respectively. In children and adolescents, injuries were caused by kitchen items, toys, foreign bodies, and direct blows by other individuals more frequently than in adults or the elderly, and by cleaning products and abrasions more frequently than in the elderly (all P < 0.05). In adults, injuries were caused by cleaning products, cooking activities, falls from height, sports equipment, penetrating or cutting, and abrasions more frequently than in children and adolescents or the elderly (all P < 0.05), and by kitchen items, toys, and blows by other individuals more frequently than in the elderly (all P < 0.05). In the elderly, injuries were caused by chemical products more frequently than in children and adolescents or adults, and by cooking activities, falls from height, and sports equipment more frequently than in children and adolescents (all P < 0.05). In adults, the frequency of ocular injuries was significantly higher in Tehran and lower in Mashhad when comparing each with that of the other four cities (all P < 0.05). We found a significantly higher frequency of ocular injuries by cleaning and chemical products in Tehran, by toys in Shiraz, by falls from height in Isfahan, and by direct blows by other individuals in Ahvaz when comparing each to that of the other four cities (all P < 0.05). Regarding the prevalence of severe ocular injuries among the children/adolescent and adult age groups, conditions were relatively better in Shiraz and relatively unfavorable in Mashhad.

Conclusions: Ocular trauma was more common in male individu

背景:在伊朗,在家中受到的眼部伤害是一个日益严重的公共卫生问题,但很少有研究对这些伤害的发生率和不同原因的频率进行探讨。我们调查了儿童和青少年(岁)在家中眼部受伤的特征:在这项横断面研究中,我们招募了在 5 个月内到 5 个大都市的 12 家公立/教学医院就诊的在家眼部受伤的患者。通过急诊科档案中的临床记录,我们收集了以下数据:年龄、性别、需要入院或手术治疗的受伤频率,以及眼部受伤的原因,包括:1)清洁产品;2)化学产品;3)厨房用品;4)烹饪活动;5)玩具;6)高空坠落;7)运动器材;8)穿透或切割;9)擦伤;10)异物;11)他人直接击打:在来自五个城市的 5008 名参与者中,74%(n = 3711)为男性,26%(n = 1297)为女性。儿童和青少年、成人以及老年人最常见的受伤原因分别是玩具、厨房用品和烹饪活动。在儿童和青少年中,厨房用品、玩具、异物和他人直接击打造成的伤害比成人或老年人更常见,而清洁用品和擦伤则比老年人更常见(均为P P P P P P P结论:眼外伤在男性和年轻群体中更为常见。大约一半的原因是厨房用品、玩具和异物,而这些都是可以通过提高公众的眼健康意识来避免的。严重眼外伤的发生率在以下年龄段的人群中较高
{"title":"Ocular injuries sustained at home in five metropolitan cities: a review of 5008 cases.","authors":"Meisam Sharifi, Mohammad Sedaghat, Mohammad Vaseie","doi":"10.51329/mehdiophthal1486","DOIUrl":"https://doi.org/10.51329/mehdiophthal1486","url":null,"abstract":"<p><strong>Background: </strong>In Iran, ocular injuries sustained at home are a growing public health issue, and few studies have explored their prevalence and the frequencies of different causes of these injuries. We investigated the features of ocular injuries at home among children and adolescents (aged < 18 years), adults (18 - 64 years), and the elderly ( ≥ 65 years) in five metropolitan cities.</p><p><strong>Methods: </strong>In this cross-sectional study, we recruited individuals with ocular injuries sustained at home who presented to 12 public/teaching hospitals in five metropolitan cities during a 5-month period. Using clinical records within the emergency department archives, we collected the following data: age, sex, frequency of injuries requiring hospital admission or surgical intervention, and causes of eye injuries, documented as 1) cleaning products, 2) chemical products, 3) kitchen items, 4) cooking activities, 5) toys, 6) falls from height, 7) sports equipment, 8) penetrating or cutting, 9) abrasions, 10) foreign bodies, and 11) direct blows by other individuals.</p><p><strong>Results: </strong>Of 5008 participants from the five cities, 74% (n = 3711) were male and 26% (n = 1297) were female. The most frequent causes of injury among children and adolescents, adults, and the elderly were toys, kitchen items, and cooking activities, respectively. In children and adolescents, injuries were caused by kitchen items, toys, foreign bodies, and direct blows by other individuals more frequently than in adults or the elderly, and by cleaning products and abrasions more frequently than in the elderly (all <i>P</i> < 0.05). In adults, injuries were caused by cleaning products, cooking activities, falls from height, sports equipment, penetrating or cutting, and abrasions more frequently than in children and adolescents or the elderly (all <i>P</i> < 0.05), and by kitchen items, toys, and blows by other individuals more frequently than in the elderly (all <i>P</i> < 0.05). In the elderly, injuries were caused by chemical products more frequently than in children and adolescents or adults, and by cooking activities, falls from height, and sports equipment more frequently than in children and adolescents (all <i>P</i> < 0.05). In adults, the frequency of ocular injuries was significantly higher in Tehran and lower in Mashhad when comparing each with that of the other four cities (all <i>P</i> < 0.05). We found a significantly higher frequency of ocular injuries by cleaning and chemical products in Tehran, by toys in Shiraz, by falls from height in Isfahan, and by direct blows by other individuals in Ahvaz when comparing each to that of the other four cities (all <i>P</i> < 0.05). Regarding the prevalence of severe ocular injuries among the children/adolescent and adult age groups, conditions were relatively better in Shiraz and relatively unfavorable in Mashhad.</p><p><strong>Conclusions: </strong>Ocular trauma was more common in male individu","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"12 4","pages":"194-202"},"PeriodicalIF":0.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular surface lesions in clinical grades of Bell's phenomenon. 贝尔现象临床分级中的眼表病变。
Q2 Medicine Pub Date : 2024-01-31 eCollection Date: 2023-01-01 DOI: 10.51329/mehdiophthal1484
Omer Faruk Yilmaz, Halit Oguz

Background: Bell's phenomenon, also known as the palpebral oculogyric reflex, is a critical reflex that protects the cornea. We developed an innovative, simple, and practical grading scale for Bell's phenomenon that includes the inverse Bell's phenomenon. Using this scale, we investigated the characteristics of Bell's phenomenon among asymptomatic individuals in different age groups and examined the frequency of ocular surface lesions in asymptomatic and symptomatic participants with different grades.

Methods: In this cross-sectional study, we randomly included 330 eyes of 165 asymptomatic, healthy, White Turkish individuals who attended the outpatient eye clinic, with a male-to-female ratio of 1:1.4, in the control group. These were categorized into four age groups: 4 - 20 years, 21 - 40 years, 41 - 60 years, and > 60 years. Eighty eyes from 40 patients with ocular surface lesions and absence of grade + 2 Bell's phenomenon were included in the symptomatic group. Bell's phenomenon was classified into five grades: grade + 2 (strong positive), grade + 1 (weak positive), grade 0 (no Bell's phenomenon, no eye movement), grade -1 (weak inverse), and grade -2 (strong inverse).

Results: We detected higher frequencies of grade + 2, + 1, and 0 in individuals aged 4 - 40, 41 - 60, and > 60 years, respectively. There was a significant difference between age groups in the frequencies of different grades (P < 0.001). Pairwise analysis revealed a significantly lower frequency of grade + 2 in the age group > 60 years compared with the 4 - 20 and 21 - 40 year groups (both P < 0.05). Grade + 2 was the most frequent in both sexes. We detected grade 0 in 27.1% of men and 22.1% of women in the control group, with no significant difference in the frequencies of different grades between sexes (P > 0.05). We observed significant differences between grades with respect to the frequency of ocular surface lesions (P < 0.001). Pairwise analysis revealed a significantly higher frequency of ocular surface lesions in asymptomatic individuals with grade 0 and all four other grades (all P < 0.001). However, the frequency of ocular surface lesions was comparable between sexes (P > 0.05). Of the 40 symptomatic individuals, 28 (70%), 5 (12.5%), 4 (10%), and 3 (7.5%) had grade 0, + 1, -1, and -2, respectively. The number of symptomatic patients was higher in grade 0 (n = 28) than in other grades (grade + 1, -1, and -2: n = 12 patients), and these individuals had a higher frequency of ocular surface lesions (n = 38 lesions) than others (grade + 1, -1, and -2: 7 lesions).

Conclusions: Using a simple, practical grading scale for Bell's phenomenon that includes inverse Bell's phenomenon, we observed that inverse Bell's phenomenon is a reflex that may be present in healthy individuals and could have a protective effect on the eye, although not to such a degr

背景:贝尔现象又称睑板眼反射,是一种保护角膜的重要反射。我们为贝尔现象制定了一个创新、简单、实用的分级表,其中包括贝尔现象的逆分级。利用该量表,我们调查了不同年龄组无症状者的贝尔现象特征,并研究了无症状者和有症状者不同等级的眼表病变频率:在这项横断面研究中,我们随机将 165 名无症状、健康的土耳其白人患者的 330 只眼睛纳入对照组,男女比例为 1:1.4。这些人被分为四个年龄组:4 - 20 岁、21 - 40 岁、41 - 60 岁和大于 60 岁。无症状组包括 40 名患者的 80 只眼睛,这些患者的眼表均有病变,且无 + 2 级贝尔现象。贝尔现象分为五个等级:+2 级(强阳性)、+1 级(弱阳性)、0 级(无贝尔现象,眼球无运动)、-1 级(弱逆性)和-2 级(强逆性):我们发现,年龄在 4 - 40 岁、41 - 60 岁和 60 岁以上的人出现 + 2 级、+ 1 级和 0 级的频率较高。不同年龄组之间不同等级的频率存在明显差异(P 60 岁组与 4 - 20 岁组和 21 - 40 岁组相比,P 均大于 0.05)。在眼表病变频率方面,我们观察到不同等级之间存在明显差异(P P > 0.05)。在 40 名有症状的患者中,分别有 28 人(70%)、5 人(12.5%)、4 人(10%)和 3 人(7.5%)患有 0 级、+1 级、-1 级和-2 级病变。与其他等级(+1、-1和-2级:12人)相比,0级(28人)的无症状患者人数较多;与其他等级(+1、-1和-2级:7人)相比,这些患者的眼表病变频率较高(38个病变):通过使用一个简单实用的贝尔现象分级表(包括反贝尔现象),我们观察到反贝尔现象是一种反射,可能存在于健康人中,并对眼睛有保护作用,尽管其程度不如强贝尔现象。我们的观察结果表明,双侧结膜钙化/Vogt 边缘束可能与 0 级和 + 1 级贝尔现象有关。我们需要进一步开展大规模研究,利用这一创新、简单、实用的分级表来确定贝尔现象在普通人群中的发生频率,并确定各等级对眼表的保护或伤害作用。
{"title":"Ocular surface lesions in clinical grades of Bell's phenomenon.","authors":"Omer Faruk Yilmaz, Halit Oguz","doi":"10.51329/mehdiophthal1484","DOIUrl":"https://doi.org/10.51329/mehdiophthal1484","url":null,"abstract":"<p><strong>Background: </strong>Bell's phenomenon, also known as the palpebral oculogyric reflex, is a critical reflex that protects the cornea. We developed an innovative, simple, and practical grading scale for Bell's phenomenon that includes the inverse Bell's phenomenon. Using this scale, we investigated the characteristics of Bell's phenomenon among asymptomatic individuals in different age groups and examined the frequency of ocular surface lesions in asymptomatic and symptomatic participants with different grades.</p><p><strong>Methods: </strong>In this cross-sectional study, we randomly included 330 eyes of 165 asymptomatic, healthy, White Turkish individuals who attended the outpatient eye clinic, with a male-to-female ratio of 1:1.4, in the control group. These were categorized into four age groups: 4 - 20 years, 21 - 40 years, 41 - 60 years, and > 60 years. Eighty eyes from 40 patients with ocular surface lesions and absence of grade + 2 Bell's phenomenon were included in the symptomatic group. Bell's phenomenon was classified into five grades: grade + 2 (strong positive), grade + 1 (weak positive), grade 0 (no Bell's phenomenon, no eye movement), grade -1 (weak inverse), and grade -2 (strong inverse).</p><p><strong>Results: </strong>We detected higher frequencies of grade + 2, + 1, and 0 in individuals aged 4 - 40, 41 - 60, and > 60 years, respectively. There was a significant difference between age groups in the frequencies of different grades (<i>P</i> < 0.001). Pairwise analysis revealed a significantly lower frequency of grade + 2 in the age group > 60 years compared with the 4 - 20 and 21 - 40 year groups (both <i>P</i> < 0.05). Grade + 2 was the most frequent in both sexes. We detected grade 0 in 27.1% of men and 22.1% of women in the control group, with no significant difference in the frequencies of different grades between sexes (<i>P</i> > 0.05). We observed significant differences between grades with respect to the frequency of ocular surface lesions (<i>P</i> < 0.001). Pairwise analysis revealed a significantly higher frequency of ocular surface lesions in asymptomatic individuals with grade 0 and all four other grades (all <i>P</i> < 0.001). However, the frequency of ocular surface lesions was comparable between sexes (<i>P</i> > 0.05). Of the 40 symptomatic individuals, 28 (70%), 5 (12.5%), 4 (10%), and 3 (7.5%) had grade 0, + 1, -1, and -2, respectively. The number of symptomatic patients was higher in grade 0 (n = 28) than in other grades (grade + 1, -1, and -2: n = 12 patients), and these individuals had a higher frequency of ocular surface lesions (n = 38 lesions) than others (grade + 1, -1, and -2: 7 lesions).</p><p><strong>Conclusions: </strong>Using a simple, practical grading scale for Bell's phenomenon that includes inverse Bell's phenomenon, we observed that inverse Bell's phenomenon is a reflex that may be present in healthy individuals and could have a protective effect on the eye, although not to such a degr","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"12 4","pages":"177-186"},"PeriodicalIF":0.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and children's eyes. COVID-19 和儿童的眼睛。
Q2 Medicine Pub Date : 2024-01-31 eCollection Date: 2023-01-01 DOI: 10.51329/mehdiophthal1488
Nima Rastegar Rad
{"title":"COVID-19 and children's eyes.","authors":"Nima Rastegar Rad","doi":"10.51329/mehdiophthal1488","DOIUrl":"https://doi.org/10.51329/mehdiophthal1488","url":null,"abstract":"","PeriodicalId":36524,"journal":{"name":"Medical Hypothesis, Discovery, and Innovation in Ophthalmology","volume":"12 4","pages":"213-216"},"PeriodicalIF":0.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Hypothesis, Discovery, and Innovation in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1